Helicobacter pylori infection in children in Estonia: Decreasing seroprevalence during the 11-year period of profound socioeconomic changes

Helicobacter

Volumn 9, Issue 3, 2004, Pages 233-241

  Oona, Marje ^a,d   Utt, Meeme ^b   Nilsson, Ingrid ^c   Uibo, Oivi ^b   Vorobjova, Tamara ^b   Maaroos, Heidi Ingrid ^a  

^a Dept of Polyclin and Fam Medicine ^*  (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c LUND UNIVERSITY   (Sweden)

^d NONE   (Estonia)

Author keywords

Children and birth cohort effect; Epidemiology; Helicobacter pylori

Indexed keywords

CELL SURFACE PROTEIN; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; DEMOGRAPHY; ECONOMIC ASPECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTONIA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; SEROPREVALENCE; SOCIAL ASPECT; SOCIOECONOMICS;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 2642550160     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1083-4389.2004.00229.x     Document Type: Article

References (52)

1. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995;9:33-9.
2. Malaty HM, El-Kasabany A, Graham DY, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002;359:931-5.
3. Parsonnet J, Blaser MJ, Perez-Perez GI, et al. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992;102:41-6.
4. Sipponen P, Kosunen TU, Samloff IM, et al. Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen year follow-up. Scand J Gastroenterol 1996;31:229-32.
5. Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994;35:742-5.
6. Gause-Nilsson I, Gnarpe H, Gnarpe J, et al. Helicobacter pylori serology in elderly people: a 21-year cohort comparison in 70-year-olds and a 20-year longitudinal population study in 70-90-year-olds. Age Ageing 1998;27:433-6.
7. Kosunen TU, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland Epidemiol Infect 1997;119:29-34.
8. Maaroos HI. Helicobacter pylori infection in Estonian population: is it a health problem? Ann Med 1995;27:613-6.
9. Vorobjova T, Kisand K, Haukañomm A, et al. The prevalence of Helicobacter pylori antibodies in a population from Southern Estonia. Eur J Gastroenterol Hepatol 1994;6:529-33.
10. Vorobjova T, Grünberg H, Oona M, et al. Seropositivity to Helicobacter pylori and CagA protein in schoolchildren of different ages living in urban and rural areas in southern Estonia. Eur J Gastroenterol Hepatol 2000;12:97-101.
11. Granström M, Tindberg Y, Blennow M. Sero-epidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J Clin Microbiol 1997;35:468-70.
12. Ashorn M, Mäki M, Hallström M, et al. Helicobacter pylori infection in Finnish children and adolescents. A serologic cross-sectional and follow-up study. Scand J Gastroenterol 1995;30:876-9.
13. Uibo O, Maaroos HI, Hospital screening of coeliac disease in Estonian children by antigliadin antibodies of IgA class. Acta Paediatr 1993;82:233-4.
14. Nilsson I, Ljungh A, Aleljung P, et al. Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J Clin Microbiol 1997;35:427-32.
15. Lindkvist P, Tammur R, Nilsson I, et al. Helicobacter pylori infection in Estonia - a three-year follow-up of children from birth. In: Risk Factors for Infection with Helicobacter Pylori [Dissertation]. Stockholm: Karolinska Institutet; 1999.
16. Guruge JL, Schalen C, Nilsson I, et al. Detection of antibodies to Helicobacter pylori cell surface antigens. Scand J Infect Dis 1990;22:457-65.
17. Maaroos HI, Nilsson I, Vorobjova T, Rägo T, Wadström T. Histological and serological examination of Helicobacter pylori in Estonian children with abdominal complaints. In: Pajares JM, Pena AS, Malfertheiner P, eds. Helicobacter pylori and Gastroduodenal Pathology. Berlin, New York: Springer-Verlag, 1993:263-9.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
19. Raymond J, Kalach N, Bergeret M, et al. Evaluation of a serological test for diagnosis of Helicobacter pylori infection in children. Eur J Clin Microbiol Infect Dis 1996;15:415-17.
20. Khanna B, Cutler A, Israel NR, et al. Use caution with serologic testing for Helicobacter pylori infection in children. J Infect Dis 1998;178:460-5.
21. Rocha GA, Oliveira AM, Queiroz DM, et al. Immunoblot analysis of humoral immune response to Helicobacter pylori in children with and without duodenal ulcer. J Clin Microbiol 2000;38:1777-81.
22. Raymond J, Sauvestre C, Kalach N, et al. Immunoblotting and serology for diagnosis of Helicobacter pylori infection in children. Pediatr Infect Dis J 2000;19:118-21.
23. Kimia A, Zahavi I, Shapiro R, et al. The role of Helicobacter pylori and gastritis in children with recurrent abdominal pain. Isr Med Assoc J 2000;2:126-8.
24. O'Donohoe JM, Sullivan PB, Scott R, Rogers T, Brueton MJ, Barltrop D. Recurrent abdominal pain and Helicobacter pylori in a community-based sample of London children. Acta Paediatr 1996;85:961-4.
25. Macarthur C. Helicobacter pylori infection and childhood recurrent abdominal pain: lack of evidence for a cause and effect relationship. Can J Gastroenterol 1999;13:607-10.
26. Macarthur C, Saunders N, Feldman W, Ipp M, Winders-Lee P, Roberts S, Best L, Sherman P, Pencharz P, Veldhuyzen van Zanten SV. Helicobacter pylori and childhood recurrent abdominal pain: community based case-control study. BMJ 1999;319:822-3.
27. Bode G, Brenner H, Adler G, et al. Recurrent abdominal pain in children. Evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. J Psychosom Res 2003;54:417-21.
28. Wewer V, Andersen LP, Paerregaard A, Gernow A, Hansen JP, Matzen P, Krasilnikoff PA. Treatment of Helicobacter pylori in children with recurrent abdominal pain. Helicobacter 2001;6:244-8.
29. Rothenbacher D, Blaser MJ, Bode G, et al. Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. J Infect Dis 2000;182:1446-9.
30. Passaro DJ, Taylor DN, Meza R, et al. Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children. Pediatrics 2001;108:E87.
31. Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21.
32. Roosendaal R, Kuipers EJ, Buitenwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997;92:1480-2.
33. Rehnberg-Laiho L, Rautelin H, Koskela P, et al. Decreasing prevalence of Helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect 2001;126:37-42.
34. Apostolopoulos P, Vafiadis-Zouboulis I, Tzivras M, et al. Helicobacter pylori (H. pylori) infection in Greece: the changing prevalence during a ten-year period and its antigenic profile. BMC Gastroenterol 2002;2:11.
35. Matysiak-Budnik T, Knapik Z, Megraud F, et al. Helicobacter pylori infection in Eastern Europe: seroprevalence in the Polish population of Lower Silesia. Am J Gastroenterol 1996;91:2513-15.
36. Malaty HM, Paykov V, Bykova O, et al. Helicobacter pylori and socioeconomic factors in Russia. Helicobacter 1996;1:82-7.
37. Parsonnet J. Factors associated with disappearance of Helicobacter pylori in the West. In: Hunt RH, Tytgat GN, eds. Helicobacter pylori Basic Mechanisms to Clinical Cure 2000. Dordrecht: Kluwer Academic Publishers, 2000:45-51.
38. Malaty HM, Kim JG, Kim SD, Graham DY. Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol 1996;143:257-62.
39. Kask U, Kõgel H, Tuvikene M. Poverty and welfare trends in Estonia over the 1990s. Estonian country report. Available from URL. http://www.unicef-icdc.org/research/ESP/CountryReports200102/Estonia01.pdf.
40. Statistical Office of Estonia 2000. Aasta rahva ja eluruumide loendus. Elamistingimused. XI 2000 Population and Housing Census. Living conditions. XI. Tallinn: Statistikaamet, 2004:19-21.
41. Kiivet RA, Bergman U, Sjöqvist F. The use of drugs in Estonia compared to the Nordic countries. Eur J Clin Pharmacol 1992;42:511-15.
42. Kiivet RA, Bergman U, Rootslane L, et al. Drug use in Estonia in 1994-95: a follow-up from 1989 and comparison with two Nordic countries. Eur J Clin Pharmacol 1998;54:119-24.
43. Jõgiste A, Aro T, Jõks U, et al. Soolenakkushaiguste diagnoosimise olukord. Eesti Arst 2003; 82:472-6.
44. Laur P. The state as an environment for health. In: Kiivet R, Harro J, eds. Eesti Rahva Tervis 1991-2002. Health in Estonia 1991-2000. Tartu: Tartu Ülikool, 2002:76.
45. Kasmel A. Dietary habits. In: Kiivet R, Harro J, eds. Eesti Rahva Tervis 1991-2002. Health in Estonia 1991-2000. Tartu: Tartu Ülikool, 2002:38-40.
46. Goodman KJ, Correa P, Tengana Aux HJ, et al. Nutritional factors and Helicobacter pylori infection in Colombian children. J Pediatr Gastroenterol Nutr 1997;25:507-15.
47. Begue RE, Gonzales JL, Correa-Gracian H, et al. Dietary risk factors associated with the transmission of Helicobacter pylori in Lima, Peru. Am J Trop Medical Hyg 1998;59:637-40.
48. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, et al. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 1998;7:449-54.
49. Zhang HM, Wakisaka N, Maeda O, et al. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer 1997;80:1897-903.
50. Wang X, Willen R, Wadström T. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob Agents Chemother 2000;44:2452-7.
51. Sjunnesson H, Sturegard E, Willen R, et al. High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the guinea pig. Comp Med 2001;51:418-23.
52. Tabak M, Armon R, Rosenblat G, et al. Diverse effects of ascorbic acid and palmitoyl ascorbate on Helicobacter pylori survival and growth. FEMS Microbiol Lett 2003;224:247-53.